271 related articles for article (PubMed ID: 28182038)
21. Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults.
Fukuda T; Yazawa H; Nishikawa R; Tokoi S; Kayashima R; Kono K; Sakuma M; Abe S; Toyoda S; Nakajima T
Cureus; 2024 May; 16(5):e60422. PubMed ID: 38883134
[TBL] [Abstract][Full Text] [Related]
22. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
Awan AA; Walther CP; Richardson PA; Shah M; Winkelmayer WC; Navaneethan SD
Nephrol Dial Transplant; 2021 Jan; 36(1):129-136. PubMed ID: 31641775
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of iron status in anemic pre-dialysis chronic kidney disease patients.
Waziri B; Babawale BT; Mabayoje MO
Niger J Clin Pract; 2022 Mar; 25(3):226-230. PubMed ID: 35295041
[TBL] [Abstract][Full Text] [Related]
25. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
[TBL] [Abstract][Full Text] [Related]
26. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
27. Iron Deficiency Anemia in Chronic Kidney Disease.
Gafter-Gvili A; Schechter A; Rozen-Zvi B
Acta Haematol; 2019; 142(1):44-50. PubMed ID: 30970355
[TBL] [Abstract][Full Text] [Related]
28. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
Ueda N; Takasawa K
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease.
Karava V; Dotis J; Kondou A; Christoforidis A; Taparkou A; Farmaki E; Economou M; Printza N
Pediatr Nephrol; 2023 Aug; 38(8):2771-2779. PubMed ID: 36862253
[TBL] [Abstract][Full Text] [Related]
30. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
31. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
33. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.
Troutt JS; Butterfield AM; Konrad RJ
J Clin Lab Anal; 2013 Nov; 27(6):504-10. PubMed ID: 24218134
[TBL] [Abstract][Full Text] [Related]
34. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
[TBL] [Abstract][Full Text] [Related]
35. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
36. Serum total iron-binding capacity and iron status in patients with non-dialysis-dependent chronic kidney disease: A cross-sectional study in Vietnam.
Thang LV; Kien NT; Hung NV; Kien TQ; Dung NH; Huong NTT; Toan ND; Toan PQ; Vinh HT; Nghia VX; Usui T
Asia Pac J Clin Nutr; 2020; 29(1):48-54. PubMed ID: 32229441
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
38. Serum hepcidin levels and iron parameters in children with iron deficiency.
Choi HS; Song SH; Lee JH; Kim HJ; Yang HR
Korean J Hematol; 2012 Dec; 47(4):286-92. PubMed ID: 23320008
[TBL] [Abstract][Full Text] [Related]
39. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome.
Kato A
Future Cardiol; 2010 Nov; 6(6):769-71. PubMed ID: 21142632
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
